As the year is nearing a close, lawmakers are still chipping away at spending bills and a long to-do list of health policy priorities that could come with some big changes for the biotech industry.
Endpoints News sat down with PureTech CEO and BIO board member Daphne Zohar to talk…
Click here to view original post
